Immunic, Inc.
DE ˙ DB
16,63 € ↓ -16,55 (-49,87%)
2019-04-18
DEL PRIS
SecurityDE:10V / Immunic, Inc.
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership121,850 shares
Latest Disclosed Value $ 135,254
Bnp Paribas Arbitrage, Sa reports 468,553.85% increase in ownership of 10V / Immunic, Inc.

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 121,850 shares of Immunic, Inc. (DE:10V) valued at $135,254 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 26 shares of Immunic, Inc.. The current value of the position is $2,026,609 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Immunic Equity 4525EP101 121,850 121,824 468,553.85 135 0.0000
2026-02-10 2025-12-31 13F Immunic Equity 4525EP101 26 0 0.00 0 0.0000
2025-11-13 2025-09-30 13F Immunic Equity 4525EP101 26 0 0.00 0 0.0000
2025-08-14 2025-06-30 13F Immunic Equity 4525EP101 26 20 333.33 0 0.0000
2025-05-14 2025-03-31 13F Immunic Equity 4525EP101 6 0 0.00 0 0.0000
2025-02-14 2024-12-31 13F Immunic Equity 4525EP101 6 0 0.00 0 0.0000
2024-11-13 2024-09-30 13F Immunic Equity 4525EP101 6 0 0.00 0 0.0000
2024-08-13 2024-06-30 13F Immunic Equity 4525EP101 6 0 0.00 0 0.0000
2024-05-01 2024-03-31 13F Immunic Equity 4525EP101 6 0 0.00 0 0.0000
2024-02-14 2023-12-31 13F/A-2 Immunic Equity 4525EP101 6 -16 -72.73 0 0.0000
2024-02-07 2023-12-31 13F/A-1 Immunic Equity 4525EP101 6 -16 0 0.0000
2024-02-07 2023-12-31 13F Immunic Equity 4525EP101 6 -16 0 0.0000
2023-11-14 2023-09-30 13F Immunic Equity 4525EP101 22 5 29.41 0 0.0000
2023-08-09 2023-06-30 13F Immunic Equity 4525EP101 17 16 1,600.00 0 0.0000
2023-05-12 2023-03-31 13F IMMUNIC EQUITY 4525EP101 1 0 0.00 0 0.0000
2023-02-14 2022-12-31 13F Immunic Equity 4525EP101 1 -93 -98.94 0 0.0000
2022-11-16 2022-09-30 13F/A-1 Immunic Equity 4525EP101 94 -1,766 -94.95 0 -100.00 0.0000
2022-11-15 2022-09-30 13F Immunic Equity 4525EP101 94 -1,766 0 0.0000
2022-08-12 2022-06-30 13F Immunic Equity 4525EP101 1,860 -425 -18.60 6 -76.00 0.0000
2022-05-18 2022-03-31 13F/A-1 Immunic Equity 4525EP101 2,285 -4,938 -68.36 26 -63.77 0.0000
2022-02-09 2021-12-31 13F IMMUNIC EQUITY 4525EP101 7,223 3,670 103.29 69 122.58 0.0001
2021-11-16 2021-09-30 13F/A-1 IMMUNIC EQUITY 4525EP101 3,553 1,884 112.88 31 55.00 0.0000
2021-11-12 2021-09-30 13F VITAL THERAPIES EQUITY 4525EP101 1,259 -410 23 0.0000
2021-08-10 2021-06-30 13F IMMUNIC EQUITY 4525EP101 1,669 356 27.11 20 0.00 0.0000
2021-05-07 2021-03-31 13F IMMUNIC EQUITY 4525EP101 1,313 290 28.35 21 33.33 0.0000
2021-02-10 2020-12-31 13F VITAL THERAPIES EQUITY 4525EP101 1,023 -236 -18.75 16 -34.78 0.0000
2020-10-30 2020-09-30 13F VITAL THERAPIES EQUITY 4525EP101 1,259 1,130 875.97 23 2,200.00 0.0000
2020-08-06 2020-06-30 13F VITAL THERAPIES EQUITY 4525EP101 129 124 2,480.00 2 5,110.00 0.0000
2020-05-13 2020-03-31 13F VITAL THERAPIES EQUITY 4525EP101 5 0 0.00 0 0.0000
2020-02-12 2019-12-31 13F VITAL THERAPIES EQUITY 4525EP101 5 -187 -97.40 0 -100.00 0.0000
2019-11-07 2019-09-30 13F VITAL THERAPIES EQUITY 4525EP101 192 0 0.00 2 -50.00 0.0000
2019-07-30 2019-06-30 13F VITAL THERAPIES EQUITY 4525EP101 192 -8,054 -97.67 2 100.00 0.0000
2019-04-25 2019-03-31 13F VITAL THERAPIES EQUITY 92847R104 8,246 6,781 462.87 2 495.24 0.0000
2019-02-12 2018-12-31 13F VITAL THERAPIES EQUITY 92847R104 1,465 -457 -23.78 0 -48.49 0.0000
2018-11-07 2018-09-30 13F VITAL THERAPIES EQUITY 92847R104 1,922 2 0.10 1 -100.00 0.0000
2018-07-25 2018-06-30 13F VITAL THERAPIES EQUITY 92847R104 1,920 994 107.34 13 116.67 0.0000
2018-05-11 2018-03-31 13F VITAL THERAPIES EQUITY 92847R104 926 0 0.00 6 20.00 0.0000
2018-03-05 2017-12-31 13F/A-1 VITAL THERAPIES EQUITY 92847R104 926 -13 -1.38 6 25.00 0.0000
2018-02-01 2017-12-31 13F VITAL THERAPIES EQUITY 92847R104 926 -13 6
2017-11-03 2017-09-30 13F VITAL THERAPIES STOCK 92847R104 939 0 0.00 5 100.00 0.0000
2017-08-03 2017-06-30 13F VITAL THERAPIES STOCK 92847R104 939 1 0.11 3 -33.33 0.0000
2017-05-03 2017-03-31 13F VITAL THERAPIES STOCK 92847R104 938 731 353.14 4 316.89 0.0000
2017-02-14 2016-12-31 13F VITAL THERAPIES STOCK 92847R104 207 -1,395 -87.08 1 -100.00 0.0000
2016-10-05 2016-09-30 13F * VITAL THERAPIES INC COM STOCK 92847R104 1,602 674 72.63 10 80.00 0.0000
2016-07-06 2016-06-30 13F * VITAL THERAPIES INC COM STOCK 92847R104 928 563 154.25 6 66.67 0.0000
2016-04-22 2016-03-31 13F * VITAL THERAPIES INC COM STOCK 92847R104 365 -2,272 -86.16 3 -90.00 0.0000
2016-04-19 2015-12-31 13F/A-1 * VITAL THERAPIES INC COM STOCK 92847R104 2,637 -1,293 -32.90 30 100.00 0.0001
2016-02-10 2015-12-31 13F * VITAL THERAPIES INC COM STOCK 92847R104 2,637 30
2015-11-13 2015-09-30 13F * VITAL THERAPIES INC COM STOCK 92847R104 3,930 2,535 181.72 16 -48.28 0.0000
2015-08-14 2015-06-30 13F VITAL THERAPIES INC COM STOCK 92847R104 1,395 1,257 910.87 29 866.67 0.0001
2015-05-15 2015-03-31 13F * VITAL THERAPIES INC COM STOCK 92847R104 138 138 0.00 3 0.0000
2015-02-11 2014-12-31 13F VITAL THERAPIES INC COM ADDED STOCK 92847R104 0 -179 -100.00 0 -100.00
2014-11-12 2014-09-30 13F VITAL THERAPIES INC COM ADDED STOCK 92847R104 179 179 4 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.